Keymed Biosciences Inc. (HKG:2162)
78.85
-1.85 (-2.29%)
Apr 17, 2026, 2:25 PM HKT
77.99% (1Y)
| Market Cap | 23.77B +125.8% |
| Revenue (ttm) | 797.12M +67.3% |
| Net Income | -581.60M |
| EPS | -2.12 |
| Shares Out | 294.60M |
| PE Ratio | n/a |
| Forward PE | 222.18 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,428,000 |
| Average Volume | 3,423,599 |
| Open | 80.85 |
| Previous Close | 80.70 |
| Day's Range | 77.50 - 81.40 |
| 52-Week Range | 37.40 - 81.85 |
| Beta | -0.25 |
| RSI | 83.20 |
| Earnings Date | Mar 26, 2026 |